AngioDynamics, Inc. (AngioDynamics), a public medical device company, is engaged in designing, developing, manufacturing and marketing therapeutic and diagnostic devices for the treatment of peripheral vascular disease (PVD) and other non-coronary diseases. It focuses on the development of innovative, minimally invasive, image-guided procedures to treat PVD and oncology therapy options including radiofrequency ablation, systems, irreversible electroporation, surgical resection systems and embolization products for the treatment of cancer. The company offers its products to interventional physicians, interventional radiologists, vascular surgeons and others. It holds three wholly owned subsidiaries and its products are sold through direct sales force in the US and through a network of distributors outside the US markets. The company operates principally in the US and Europe. It is headquartered in New York, the US.